Biotechnology has emerged as one of the most promising and potentially profitable fields for venture capital, the government, health practitioners, consumers, and patients. Some biotechnological companies like 23andMe promise clients access to their ancient ancestry with a simple DNA swab. Scientists have harnessed the power of cloning that promises miraculous cures through stem cell therapies. Many patients have pinned their hopes in the secrets of the BRCA genes to find that elusive cure fo...

Seminar Required